AHCL Share Price | Anlon Healthcare Ltd Stock Analysis & Recommendation

Q: Why is Anlon Healthcare Ltd falling/rising?

As of 18-Apr, Anlon Healthcare Ltd's stock price is rising, currently at 141.50, reflecting a change of 0.3 (0.21%) upward. The stock has shown significant performance over the past 11 days, gaining 27.13% during this period. Additionally, it has outperformed the benchmark Sensex in both the 1-week and 1-month periods, with returns of +8.76% and +22.04%, respectively, compared to the Sensex's +1.22% and +3.18%.The stock is also trading above its moving averages across various time frames, indicating a strong upward trend. However, it is important to note that there has been a decline in investor participation, with delivery volume dropping by 26.06% against the 5-day average. Despite this decrease in participation, the overall performance and consecutive gains contribute to the stock's rising price.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

3.44 lacs (-57.66%) Volume

Shareholding (Mar 2026)

FII

0.32%

Held by 5 FIIs

DII

4.54%

Held by 1 DIIs

Promoter

52.68%

When is the next results date for Anlon Healthcare Ltd?

04-Feb-2026

The next results date for Anlon Healthcare Ltd is 09 February 2026.

View full answer

Why is Anlon Healthcare Ltd falling/rising?

19-Apr-2026

As of 18-Apr, Anlon Healthcare Ltd's stock price is at 141.50, having risen 27.13% over the past 11 days and outperforming the Sensex in both the 1-week and 1-month periods. Despite a decline in investor participation, the stock remains above its moving averages, indicating a strong upward trend.

View full answer

Which are the latest news on Anlon Healthcare?

19-Apr-2026

When is the next results date for Anlon Healthcare Ltd?

Compare Anlon Healthcare with Similar Stocks

Remus Pharma.Shree Ganesh Rem Kopran

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 747 Cr (Micro Cap)

P/E

48.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.07

Return on Equity

9.57%

Price to Book

3.51

Revenue and Profits:

Net Sales:

36 Cr

(Quarterly Results - Dec 2025)

Net Profit:

5 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

2.72%

6 Months

11.77%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Anlon Healthcare for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

When is the next results date for Anlon Healthcare Ltd?

The next results date for Anlon Healthcare Ltd is scheduled for 09 February 2026....

Read full news article

Announcements

Board Meeting Outcome for For Entered Into Share Purchase Agreement With Remember India Health Links Private Limited

16-Apr-2026 | Source : BSE

We have attached herewith outcome of Board Meeting held on Thursday April 16 2026. Kindly take the same on your record. Thank you.

Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

16-Apr-2026 | Source : BSE

We have attached herewith announcement as per Reg. 30 of SEBI (LODR) Regulation 2015. Kindly take the same on your record. Thank you.

Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

15-Apr-2026 | Source : BSE

Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Sr. No.	Particulars	Details
1	Name of Company	Anlon Healthcare Ltd
2	CIN NO.	U24230GJ2013PLC077543
3	Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)	27.00
4	Highest Credit Rating during the previous FY	NA
4a	Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)	Not Applicable
5	Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework	BSE

We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No

Name of the Company Secretary: Amita Pragada
Designation: Company Secretary and Compliance Officer
EmailId: cs@anloncro.com

Name of the Chief Financial Officer: Naimish Bhatt
Designation: Chief Financial Officer
EmailId: accounts@anloncro.com

Date: 15/04/2026

Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

Anlon Healthcare Ltd has announced 2:10 stock split, ex-date: 24 Apr 26

BONUS

Anlon Healthcare Ltd has announced 1:1 bonus issue, ex-date: 24 Apr 26

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

65.60%

EBIT Growth (5y)

58.45%

EBIT to Interest (avg)

8.18

Debt to EBITDA (avg)

2.57

Net Debt to Equity (avg)

0.70

Sales to Capital Employed (avg)

0.86

Tax Ratio

23.69%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

4.92%

ROCE (avg)

9.07%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.51

EV to EBIT

25.19

EV to EBITDA

23.80

EV to Capital Employed

3.35

EV to Sales

6.37

PEG Ratio

Dividend Yield

ROCE (Latest)

13.30%

ROE (Latest)

9.57%

Technicals key factors

Indicator

Weekly

Monthly

MACD

RSI

No Signal

Bollinger Bands

Bullish

KST

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 5 FIIs (0.32%)

Promoter with highest holding

Punitkumar R Rasadia (34.98%)

Highest Public shareholder

Shree Dwarikadhish Ventures Llp (7.53%)

Individual Investors Holdings

24.38%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -31.84% vs 56.76% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -44.74% vs 162.54% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "35.58",
          "val2": "52.20",
          "chgp": "-31.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "12.34",
          "val2": "13.73",
          "chgp": "-10.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.58",
          "val2": "0.87",
          "chgp": "81.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "5.15",
          "val2": "9.32",
          "chgp": "-44.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "34.68%",
          "val2": "26.30%",
          "chgp": "8.38%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "85.50",
          "val2": "62.00",
          "chgp": "37.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "19.98",
          "val2": "14.45",
          "chgp": "38.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.68",
          "val2": "1.91",
          "chgp": "-12.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "12.86",
          "val2": "6.36",
          "chgp": "102.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.37%",
          "val2": "23.31%",
          "chgp": "0.06%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "121.08",
          "val2": "71.36",
          "chgp": "69.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "32.32",
          "val2": "15.03",
          "chgp": "115.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.26",
          "val2": "2.80",
          "chgp": "16.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "18.01",
          "val2": "3.87",
          "chgp": "365.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.69%",
          "val2": "21.06%",
          "chgp": "5.63%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "120.29",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "32.21",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "3.72",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "20.52",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.78%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

35.58

52.20

-31.84%

Operating Profit (PBDIT) excl Other Income

12.34

13.73

-10.12%

Interest

1.58

0.87

81.61%

Exceptional Items

0.00

Standalone Net Profit

5.15

9.32

-44.74%

Operating Profit Margin (Excl OI)

34.68%

26.30%

8.38%

Values in Rs Cr.

Compare with Peers

Net Sales
QoQ Growth in quarter ended Dec 2025 is -31.84% vs 56.76% in Sep 2025

Standalone Net Profit
QoQ Growth in quarter ended Dec 2025 is -44.74% vs 162.54% in Sep 2025

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

85.50

62.00

37.90%

Operating Profit (PBDIT) excl Other Income

19.98

14.45

38.27%

Interest

1.68

1.91

-12.04%

Exceptional Items

0.00

Standalone Net Profit

12.86

6.36

102.20%

Operating Profit Margin (Excl OI)

23.37%

23.31%

0.06%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

121.08

71.36

69.67%

Operating Profit (PBDIT) excl Other Income

32.32

15.03

115.04%

Interest

3.26

2.80

16.43%

Exceptional Items

0.00

Standalone Net Profit

18.01

3.87

365.37%

Operating Profit Margin (Excl OI)

26.69%

21.06%

5.63%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'25

Mar'25

Change(%)

Net Sales

120.29

Operating Profit (PBDIT) excl Other Income

32.21

Interest

3.72

Exceptional Items

0.00

Standalone Net Profit

20.52

Operating Profit Margin (Excl OI)

26.78%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About Anlon Healthcare Ltd

Anlon Healthcare Ltd

Micro Cap

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

Stock List

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other

InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates

GET THE MARKETSMOJO APP

Company

Stocks

Portfolio

Market

Markets Today
Earnings
News
IPO

Webinars

"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."